[DOI] [PMC free article] [PubMed] [Google Scholar] 65.Xing L, Dai Z, Jabbari A, Cerise JE, Higgins CA, Gong W, de Jong A, Harel S, DeStefano GM, Rothman L, Singh P, Petukhova L, Mackay-Wiggan J, Christiano AM, Clynes R
Both semaglutide and tirzepatide mimic the glucagon-like peptide-1 (GLP-1) hormone that controls appetite and blood sugar to help you feel full longer and slow digestion
GHK-Cu in Thailand: Access, Standards, and Clinical Process Prescription required: GHK-Cu must be dispensed by a licensed physician following a clinical assessment
*Correspondence: Weici Wang [email protected] Ye [email protected] These authors have contributed equally to this work and share first authorship This article was submitted to Infectious Diseases - Surveillance, Prevention and Treatment, a section of the journal Frontiers in Public Health Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
GLP-1 agonists are known to have a fortuitous side effect of improving metabolic health, but how this is regulated in the body remains unclear
Healthcare providers can tailor advice based on age-specific needs